CVS

CVS HEALTH
D

CVS

Arincen56/100B

CVS HEALTH operating income 1985–2026

CVS HEALTH's operating income in Q3 FY2026, the three months to 30 September 2026, was 3.57B USD, against a loss of 3.21B USD on the same quarter a year before. CVS HEALTH's operating income over the last twelve months was 15.06B USD, up 206.4% on the twelve months before. In fiscal year 2025 it was 10.39B USD, up 21.9% on the year before.

Last updated 6 Nov 2026 · Next report 9 Feb 2027

Operating income

Operating income · +0.9% a year over 10 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM30 Sept 202615.06B+206.37%3.58%59.84B14.23%19.70B
FY202531 Dec 202510.39B+21.95%2.58%55.36B13.77%9.86B
FY202431 Dec 20248.52B-38.03%2.28%51.40B13.79%13.68B
FY202331 Dec 202313.74B+72.78%3.84%54.43B15.21%18.20B
FY202231 Dec 20227.95B-40.24%2.47%54.50B16.90%12.35B
FY202131 Dec 202113.31B-4.32%4.56%52.12B17.84%17.53B
FY202031 Dec 202013.91B+16.05%5.18%49.05B18.25%17.12B
FY201931 Dec 201911.99B+198.11%4.67%45.53B17.73%16.40B
FY201831 Dec 20184.02B-57.84%2.07%31.54B16.21%6.74B
FY201731 Dec 20179.54B-8.16%5.16%28.53B15.44%11.81B
FY201631 Dec 201610.39B+9.61%5.85%28.83B16.24%12.19B
FY201531 Dec 20159.48B+7.68%6.18%26.53B17.31%11.57B
FY201431 Dec 20148.80B+9.48%6.31%25.37B18.20%10.22B
FY201331 Dec 20138.04B+11.47%6.34%23.78B18.76%9.92B
FY201231 Dec 20127.21B+13.88%5.86%22.49B18.27%8.62B
FY201131 Dec 20116.33B+3.16%5.91%20.56B19.20%7.90B
FY201031 Dec 20106.14B-4.48%6.41%20.22B21.11%7.61B
FY200931 Dec 20096.43B+6.27%6.54%20.36B20.73%7.82B
FY200831 Dec 20086.05B+26.13%6.91%18.29B20.91%7.34B
FY200731 Dec 20074.79B+96.32%6.28%16.11B21.10%5.89B
FY200631 Dec 20062.44B+20.90%5.57%11.74B26.80%3.17B
FY200531 Dec 20052.02B+38.83%5.46%9.69B26.20%2.61B
FY200431 Dec 20041.45B+2.18%4.75%8.03B26.25%1.95B
FY200331 Dec 20031.42B+18.02%5.35%6.86B25.81%1.77B
FY200231 Dec 20021.21B+56.53%4.99%6.07B25.10%1.52B
FY200131 Dec 2001770.60M-41.74%3.46%5.69B25.59%1.44B
FY200031 Dec 20001.32B+16.49%6.58%5.36B26.69%1.62B
FY199931 Dec 19991.14B+22.03%6.27%4.86B26.86%1.41B
FY199831 Dec 1998930.50M+32.15%6.09%4.13B27.03%1.18B
FY199731 Dec 1997704.10M+16.44%5.12%3.72B27.07%946.70M
FY199631 Dec 1996604.70M+52.62%5.11%3.36B28.38%867.50M
FY199531 Dec 1995396.20M-35.12%4.06%2.90B29.75%723.90M
FY199431 Dec 1994610.70M-2.02%5.41%4.03B35.74%817.00M
FY199331 Dec 1993623.30M+72.71%5.97%3.77B36.14%814.90M
FY199231 Dec 1992360.90M-46.10%3.46%3.90B37.42%561.90M
FY199131 Dec 1991669.60M+0.81%6.77%3.72B37.65%808.10M
FY199031 Dec 1990664.20M+0.50%7.65%3.31B38.15%778.60M
FY198931 Dec 1989660.90M+12.09%8.75%2.99B39.58%758.70M
FY198831 Dec 1988589.60M+12.61%8.70%2.69B39.74%671.80M
FY198731 Dec 1987523.60M+8.29%8.83%2.36B39.84%595.60M
FY198631 Dec 1986483.50M+7.68%9.19%2.12B40.31%547.60M
FY198531 Dec 1985449.00M—9.40%1.92B40.23%512.10M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about CVS HEALTH's operating income

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.